Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age
Conditions: SARS-CoV-2 Infection; COVID-19 Interventions: Biological: BNT162b2; Other: Placebo; Biological: Seasonal Inactivated Influenza Vaccine Sponsors: Pfizer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
Conditions: COVID-19 Vaccine Uptake Interventions: Behavioral: REDES; Behavioral: Control Sponsors: Johns Hopkins University; National Institute on Minority Health and Health Disparities (NIMHD); Rutgers University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers
Conditions: Coronavirus Interventions: Biological: OVX033; Biological: Saline solution Sponsors: Osivax; Centre for the Evaluation of Vaccination H ôpital Cochin Assistance Publique - Hôpitaux de Paris (APHP) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Conditions: Health Behavior; Colorectal Cancer; Influenza; COVID-19; Vaccine Hesitancy; Vaccine-Preventable Diseases; Healthcare Patient Acceptance Interventions: Behavioral: Financial incentive for colorectal cancer screening; Behavioral: Financial incentive for flu shot; Behavioral: Financial incentive for COVID-19 shot Sponsors: Tulane University; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression
Conditions: Misinformation; Vaccine Hesitancy; Anxiety; Depression; COVID-19 Interventions: Behavioral: Attitudinal inoculation; Behavioral: Cognitive-behavioral therapy-informed intervention; Behavioral: Conventional public health messaging Sponsors: City University of New York, School of Public Health; University of North Carolina, Chapel Hill Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Effects of Oral Iron Supplementation Before vs at Time of Vaccination on Immune Response in Iron Deficient Kenyan Women
Conditions: Iron Deficiency Anemia Interventions: Dietary Supplement: Iron supplementation; Biological: MenACWY vaccine; Biological: COVID-19 vaccine; Other: Placebo; Biological: Typhim Vi vaccine Sponsors: Swiss Federal Institute of Technology; Jomo Kenyatta University of Agriculture and Technology; University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
A Phase Ⅱ Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 (COVID-19) Vaccine( ZSVG-02-O)
Conditions: SARS-CoV-2 Infection Interventions: Biological: COVID-19 mRNA Vaccine (ZSVG-02-O); Biological: COVID-19 mRNA Vaccine (ZSVG-02-O); Biological: COVID-19 Vaccine (Vero Cell) ,Inactivated Sponsors: CNBG-Virogin Biotech (Shanghai) Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine
Conditions: Myocarditis, Pericarditis Interventions: Biological: mRNA-1273 Sponsors: ModernaTX, Inc.; Lead Scientific and Operating Center: Julius Clinical Research Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Phase Ⅰ Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 (COVID-19) Vaccine( ZSVG-02-O)
Conditions: SARS-CoV-2 Infection Interventions: Biological: COVID-19 mRNA Vaccine (ZSVG-02-O); Biological: Placebo; Biological: COVID-19 Vaccine (Vero Cell) ,Inactivated Sponsors: CNBG-Virogin Biotech (Shanghai) Ltd.; Shulan (Hangzhou) Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Phase Ⅱ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
Conditions: SARS-CoV-2 Infection Interventions: Biological: COVID-19 mRNA Vaccine (ZSVG-02-O); Biological: COVID-19 mRNA Vaccine (ZSVG-02-O); Biological: COVID-19 Vaccine (Vero Cell) ,Inactivated Sponsors: CNBG-Virogin Biotech (Shanghai) Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
Conditions: SARS-CoV-2 Infection Interventions: Biological: Placebo; Biological: COVID-19 Vaccine (Vero Cell) ,Inactivated; Biological: COVID-19 mRNA Vaccine (ZSVG-02-O) 10 μg; Biological: COVID-19 mRNA Vaccine (ZSVG-02-O) 30 μg; Biological: COVID-19 mRNA Vaccine (ZSVG-02-O) 60 μg Sponsors: CNBG-Virogin Biotech (Shanghai) Ltd.; Shulan (Hangzhou) Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution
October 30, 2023 -- As COVID-19 continues to impact our communities, and winter approaches—bringing with it increases in respiratory infections—it’s important to stay vigilant and up to date on vaccines and to understand how to... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 30, 2023 Category: Pharmaceuticals Source Type: clinical trials
COVID-19 Post-Vaccination Observation
Conditions: Immune System Diseases; COVID-19 Vaccine Adverse Reaction; Immune System Disorder Sponsors: Yang I. Pachankis, PhD Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Prevalence of ENT Diseseas
Conditions: Conscripts; Military Induction Board; ENT Disease; Rhinosinusitis Chronic; Rhinosinusitis; HPV Infection; HPV Vaccine; Long COVID; ENT Surgery Sponsors: Medical University of Graz Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Lead formulations evaluated in the Phase 1/2 study demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains
Safety profile of the mRNA-based combination vaccine candidates consistent with the companies’... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 26, 2023 Category: Pharmaceuticals Source Type: clinical trials
